Echosens North America

We envision a future where medical professionals and their patients have the best tools and information to simply and effectively assess and manage liver health

[Echosens North America @echosensNA]

To stay up-to-date on the latest trends and news in non-invasive chronic liver disease management, follow us on @Echosens global page. 👍 #liverhealthmatters
https://t.co/H4VAXAysiV

[Echosens North America @echosensNA]

Are you aware of the relationship between #NAFLD, an asymptomatic condition characterized by elevated levels of fat in the liver, and #diabetes?

Find out why #T2DM patients should be monitored for #NAFLD.

https://t.co/p2MqzzqJSt

[Echosens North America @echosensNA]

New recommendations from the USPSTF recommend screening for #HBV infection in adolescents and adults at increased risk for infection.

Learn more:
https://t.co/uvQl1LTCBY

[Phil Newsome @phil_newsome7]

🙌#easl

[Echosens North America @echosensNA]

Join echosens in our next educational webinar as we welcome physician expert Dr. Caroline Apovian, the Director of Nutrition and Weight Management at Boston Medical Center.

Click for details!
https://t.co/gPnk7mOTlO

[Echosens North America @echosensNA]

The silent liver diseases you need to know about, #NAFLD and #NASH. Affecting the livers of more than 100 million Americans, NAFLD and NASH can lead to cirrhosis of the #liver and liver cancer.

Get the facts so you can prevent these diseases:
https://t.co/xgu5CzOqhK

[Echosens North America @echosensNA]

Fatty liver disease is a chronic liver disease and a rapidly growing problem. Find out how Dr. Richard Gilroy of Intermountain Healthcare's liver transplantation program is addressing this problem.

https://t.co/ZfndYrZXg7

#liverhealthmatters #NAFLD

[Echosens North America @echosensNA]

A recent study unveiled that #FibroScan was highly effective at non-invasively assessing liver fibrosis in #alcoholic patients and that instant screening of liver fibrosis in heavy drinkers is feasible without a liver biopsy.

Learn more: https://t.co/RsOYTzs6we

[Echosens North America @echosensNA]

April is #alcoholawarenessmonth! Did you know an estimated 7% of the US population meets the criteria for #alcoholabuse? These individuals are at increased risk of developing #alcoholicliverdisease, the 8th most common cause of mortality in the US.

#liverhealthmatters

[Echosens North America @echosensNA]

Clinically #alcoholicliverdisease patients can be asymptomatic or present with acute severe alcoholic hepatitis with and without #cirrhosis.

[Echosens North America @echosensNA]

From all of us at Echosens, a special thank you to all the doctors and healthcare professionals for everything they are doing to fight #COVID19. #healthcareheroes

[Echosens North America @echosensNA]

Worldwide, 292M people are chronically infected with chronic hepatitis B. Find out the impact #NASH has on these individuals in the latest webinar from Dr. Robert Gish, the Medical Director of The Hepatitis B Foundation.

Register Today:
https://t.co/ecR1E8E6mk

[Echosens North America @echosensNA]

Discover new innovative tools that support diagnosis efficiency, improve accuracy and reduce costs in the battle against #liverdisease.

https://t.co/RqfrVTcUJx

#liverhealthmatters

[Ed Tate @edwardtate]

Thank you to Dr. Gish & the good folks @EchosensNA for making this webinar happen. @HepBFoundation

[Echosens North America @echosensNA]

Join Echosens as we welcome Dr. Robert Gish, the Medical Director for the Hepatitis B Foundation, as he presents new findings on the intersection of #HBV, #NASH and #T2DM.

Learn More:
https://t.co/SFvSCWdY33

[Echosens North America @echosensNA]

Echosens proudly announces its collaboration with MetaPhy Health to support turn-key, comprehensive #chronicliverdisease management services to #gastroenterology practices for their patients with #fattyliverdisease.

Learn More: https://t.co/1G9muuWlY8

[Echosens North America @echosensNA]

Today is #diabetesalertday!

Did you know that the prevalence of #NAFLD has increased in parallel with the epidemics of #T2DM and #obesity?

Help us raise awareness of the relationship between #NAFLD and #diabetes.

Learn more:
https://t.co/AfIHtXpUbe

#liverhealthmatters

[Echosens North America @echosensNA]

Today is #diabetesalertday!

Did you know that the prevalence of #NAFLD has increased in parallel with the epidemics of #T2DM and #obesity?

Help us raise awareness of the relationship between #NAFLD and #diabetes.

Learn more:
https://t.co/CHg9lk9OAG

#liverhealthmatters

[Echosens North America @echosensNA]

Echosens has arranged an independent assessment conducted by Santa Barbara Actuaries, a healthcare consulting firm specializing in predictive modeling and analytics, to determine the cost savings of #FibroScan care models at the #pointofcare.

Learn More:
https://t.co/rZxevUvzz2

[Phil Newsome @phil_newsome7]

#easl